Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jul 16, 2015 at 12:20 PM EDT

NantKwest Sets Price Range for IPO

NantKwest has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Jul 16, 2015 at 10:05 AM EDT

UnitedHealth Q2 Earnings Beat Fails to Impress

UnitedHealth reported better-than-expected second-quarter financial results Thursday before the markets opened.

Chris Lange | Jul 15, 2015 at 1:05 PM EDT

Is Celgene Transforming Itself With Mergers and Pacts?

Celgene and Receptos announced Tuesday that they had signed a definitive agreement in which the former will acquire the latter…

Chris Lange | Jul 15, 2015 at 11:45 AM EDT

Why Aetna Is Now a Bargain

Argus thinks the sell-off in Aetna stock following the Humana merger announcement on July 3 presents a buying opportunity.

Jon C. Ogg | Jul 15, 2015 at 10:55 AM EDT

Is T2 Biosystems Really Worth 50% More?

T2 Biosystems was reiterated as Buy at Janney Capital, and the firm said that it sees a fair value estimate…

Chris Lange | Jul 15, 2015 at 9:35 AM EDT

ProNai Therapeutics Sets Price for IPO

ProNai Therapeutics has set the price for its initial public offering (IPO) that values it up to roughly $158 million.

Trey Thoelcke | Jul 15, 2015 at 7:20 AM EDT

Why Teva Pharmaceutical Bid for Mylan May Go Hostile

Teva could be about to enter the largest generic market by prescription in the world, which may tip the scales…

Chris Lange | Jul 14, 2015 at 4:14 PM EDT

BioCardia Sets Price For IPO

ThinkstockBioCardia, Inc. filed an amended S-1 form with the Securities and Exchange Commission (SEC) regarding its initial public offering. In…

Chris Lange | Jul 14, 2015 at 10:50 AM EDT

Why Biogen Is Now a Buy on Weakness

Merrill Lynch sees Biogen returning to these heightened levels, with its pipeline acting as the primary catalyst.

Lee Jackson | Jul 14, 2015 at 10:20 AM EDT

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for…

Chris Lange | Jul 14, 2015 at 8:40 AM EDT

Johnson & Johnson Posts Q2 Earnings Beat

Johnson & Johnson reported better-than-expected second-quarter financial results before the markets opened Tuesday.

Chris Lange | Jul 13, 2015 at 11:50 AM EDT

Neos Therapeutics Sets Price for IPO

Neos Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) to price its initial public offering (IPO).

Chris Lange | Jul 13, 2015 at 11:10 AM EDT

What to Expect From Johnson & Johnson Earnings

Johnson & Johnson is expected to report its second-quarter financial results Tuesday morning before the markets open.

Chris Lange | Jul 13, 2015 at 8:05 AM EDT

Short Sellers Run for Cover in Big Pharma

The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short…

Chris Lange | Jul 13, 2015 at 7:55 AM EDT

Short Sellers Back Off Big Biotech

24/7 Wall St. has reviewed the short interest in top biotech companies, without focusing on speculative companies.

1 … 256 257 258 259 260 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

NantKwest Sets Price Range for IPO

UnitedHealth Q2 Earnings Beat Fails to Impress

Is Celgene Transforming Itself With Mergers and Pacts?

Why Aetna Is Now a Bargain

Is T2 Biosystems Really Worth 50% More?

ProNai Therapeutics Sets Price for IPO

Why Teva Pharmaceutical Bid for Mylan May Go Hostile

BioCardia Sets Price For IPO

Why Biogen Is Now a Buy on Weakness

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Johnson & Johnson Posts Q2 Earnings Beat

Neos Therapeutics Sets Price for IPO

What to Expect From Johnson & Johnson Earnings

Short Sellers Run for Cover in Big Pharma

Short Sellers Back Off Big Biotech

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

NantKwest Sets Price Range for IPO

UnitedHealth Q2 Earnings Beat Fails to Impress

Is Celgene Transforming Itself With Mergers and Pacts?

Why Aetna Is Now a Bargain

Is T2 Biosystems Really Worth 50% More?

ProNai Therapeutics Sets Price for IPO

Why Teva Pharmaceutical Bid for Mylan May Go Hostile

BioCardia Sets Price For IPO

Why Biogen Is Now a Buy on Weakness

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Johnson & Johnson Posts Q2 Earnings Beat

Neos Therapeutics Sets Price for IPO

What to Expect From Johnson & Johnson Earnings

Short Sellers Run for Cover in Big Pharma

Short Sellers Back Off Big Biotech

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how